These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35081458)

  • 1. Effect of desmopressin acetate on acute spontaneous intracranial hemorrhage in patients on antiplatelet therapy.
    McManus J; Ferreira J; Jones GM; Smetana KS; Smith Condeni M; Berger K; Witenko C; Smotherman C; Gautam S; Pizzi MA; Erdman MJ
    J Neurol Sci; 2022 Mar; 434():120142. PubMed ID: 35081458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter retrospective study evaluating the impact of desmopressin on hematoma expansion in patients with antiplatelet-associated intracranial hemorrhage.
    Summers A; Singh J; Lai M; Schomer KJ; Martin R; Vitt JR; Derry KL; Box K; Chu F; Arias V; Minokadeh A; Stern-Nezer S; Groysman L; Lee BJ; Atallah S
    Thromb Res; 2023 Feb; 222():96-101. PubMed ID: 36610266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use.
    Gunther M; Witenko CJ; Prust M; Salerno D; Berger K
    J Intensive Care Med; 2022 Jun; 37(6):825-832. PubMed ID: 34286612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of desmopressin (DDAVP) in preventing hematoma expansion in intracranial hemorrhage associated with antiplatelet drugs use: A systematic review and metaanalysis.
    Shahzad F; Ahmed U; Muhammad A; Shahzad F; Naufil SI; Sukkari MW; Kamran AB; Murtaza S; Khalid MB; Shabbir H; Saeed S
    Brain Behav; 2024 May; 14(5):e3540. PubMed ID: 38778788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Desmopressin on Hematoma Expansion in Patients with Mild Traumatic Brain Injury Prescribed Pre-injury Antiplatelet Medications.
    Barletta JF; Abdul-Rahman D; Hall ST; Mangram AJ; Dzandu JK; Frontera JA; Zach V
    Neurocrit Care; 2020 Oct; 33(2):405-413. PubMed ID: 31898177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Assessment of Desmopressin Effectiveness and Safety in Patients With Antiplatelet-Associated Intracranial Hemorrhage.
    Feldman EA; Meola G; Zyck S; Miller CD; Krishnamurthy S; Cwikla GM; Darko W; Jennings S; Sullivan R; Seabury R
    Crit Care Med; 2019 Dec; 47(12):1759-1765. PubMed ID: 31567345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Administration of Desmopressin and Platelet Transfusion for Reducing Hematoma Expansion in Patients With Acute Antiplatelet Therapy Associated Intracerebral Hemorrhage.
    Mengel A; Stefanou MI; Hadaschik KA; Wolf M; Stadler V; Poli K; Lindig T; Ernemann U; Grimm F; Tatagiba M; Ziemann U; Poli S
    Crit Care Med; 2020 Jul; 48(7):1009-1017. PubMed ID: 32304415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Desmopressin on Platelet Dysfunction During Antiplatelet Therapy: A Systematic Review.
    Andersen LK; Hvas AM; Hvas CL
    Neurocrit Care; 2021 Jun; 34(3):1026-1046. PubMed ID: 32748210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cohort analysis of desmopressin effect on hematoma expansion in patients with spontaneous intracerebral hemorrhage and documented pre-ictus antiplatelet use.
    Schmidt KJ; Sager B; Zachariah J; Raad BF; James EG; Fletcher JJ
    J Clin Neurosci; 2019 Aug; 66():33-37. PubMed ID: 31160199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a TEG-Platelet Mapping Algorithm to Guide Reversal of Antiplatelet Agents in Adults with Mild-to-Moderate Traumatic Brain Injury: An Observational Pilot Study.
    Kvint S; Gutierrez A; Venezia A; Maloney E; Schuster J; Kumar MA
    Neurocrit Care; 2022 Dec; 37(3):638-648. PubMed ID: 35705826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of desmopressin on hematoma expansion in antiplatelet-associated intracerebral hemorrhage: A systematic review and meta-analysis.
    Loggini A; El Ammar F; Darzi AJ; Mansour A; Kramer CL; Goldenberg FD; Lazaridis C
    J Clin Neurosci; 2021 Apr; 86():116-121. PubMed ID: 33775314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin Administration and Impact on Hypertonic Saline Effectiveness in Intracranial Hemorrhage.
    Bowers E; Shaw E; Bromberg W; Johnson A
    Neurocrit Care; 2022 Feb; 36(1):164-170. PubMed ID: 34235613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet Medication Reversal Strategies in Operative Intracranial Hemorrhage: A Survey of Practicing Neurosurgeons.
    Foreman PM; Ilyas A; Mooney J; Schmalz PGR; Walters BC; Griessenauer CJ
    World Neurosurg; 2018 Aug; 116():e649-e654. PubMed ID: 29783009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Platelet and Desmopressin Administration on Early Radiographic Progression of Traumatic Intracranial Hemorrhage.
    Kim DY; O'Leary M; Nguyen A; Kaji A; Bricker S; Neville A; Bongard F; Putnam B; Plurad D
    J Neurotrauma; 2015 Nov; 32(22):1815-21. PubMed ID: 25604812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage.
    Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; DeRosa PA; Landes E; Lei S; Khandji J; Gutbrod S; Connolly ES
    Neurol Res; 2010 Sep; 32(7):706-10. PubMed ID: 20819399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review.
    Campbell PG; Sen A; Yadla S; Jabbour P; Jallo J
    World Neurosurg; 2010; 74(2-3):279-85. PubMed ID: 21492561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study of DDAVP versus platelet transfusions for antiplatelet agent reversal in patients with traumatic brain injury.
    Westfall KM; Andrews J; Sadek E; Curtiss W; Hecht J
    Neurol Sci; 2024 Jul; 45(7):3325-3332. PubMed ID: 38353847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of intracranial hemorrhage in patients with left ventricular assist devices.
    Wilson TJ; Stetler WR; Al-Holou WN; Sullivan SE; Fletcher JJ
    J Neurosurg; 2013 May; 118(5):1063-8. PubMed ID: 23451903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage.
    Nguyen T; Sharma M; Crooks P; Patel PV; Bonow RH; Creutzfeldt CJ; Wahlster S
    Br J Neurosurg; 2022 Apr; 36(2):251-257. PubMed ID: 35343356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resumption of antiplatelet therapy in patients with primary intracranial hemorrhage-benefits and risks: A meta-analysis of cohort studies.
    Ding X; Liu X; Tan C; Yin M; Wang T; Liu Y; Mo L; Wei X; Tan X; Deng F; Chen L
    J Neurol Sci; 2018 Jan; 384():133-138. PubMed ID: 29153510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.